Matches in Wikidata for { <http://www.wikidata.org/entity/Q37296336> ?p ?o ?g. }
- Q37296336 description "article científic" @default.
- Q37296336 description "article scientifique" @default.
- Q37296336 description "articolo scientifico" @default.
- Q37296336 description "artigo científico" @default.
- Q37296336 description "artículu científicu espublizáu en 2014" @default.
- Q37296336 description "bilimsel makale" @default.
- Q37296336 description "scientific article published on September 2014" @default.
- Q37296336 description "vedecký článok" @default.
- Q37296336 description "vetenskaplig artikel" @default.
- Q37296336 description "videnskabelig artikel" @default.
- Q37296336 description "vědecký článek" @default.
- Q37296336 description "wetenschappelijk artikel" @default.
- Q37296336 description "wissenschaftlicher Artikel" @default.
- Q37296336 description "наукова стаття, опублікована у вересні 2014" @default.
- Q37296336 description "научни чланак" @default.
- Q37296336 description "مقالة علمية نشرت في سبتمبر 2014" @default.
- Q37296336 name "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis" @default.
- Q37296336 name "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis" @default.
- Q37296336 name "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor" @default.
- Q37296336 type Item @default.
- Q37296336 label "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis" @default.
- Q37296336 label "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis" @default.
- Q37296336 label "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor" @default.
- Q37296336 prefLabel "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis" @default.
- Q37296336 prefLabel "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis" @default.
- Q37296336 prefLabel "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor" @default.
- Q37296336 P1433 Q37296336-2F8F3142-9DB6-4DF6-98C9-692B505830F9 @default.
- Q37296336 P1476 Q37296336-63B5BBB0-C5AF-40B1-A01C-6F4C724B4C37 @default.
- Q37296336 P2093 Q37296336-05678540-7CF1-4FCB-87F8-BC1825AF6659 @default.
- Q37296336 P2093 Q37296336-22FB1459-346D-4366-A984-9CB77C788B88 @default.
- Q37296336 P2093 Q37296336-365C00BB-F7F1-4FF2-AB78-6DCE064F0A5C @default.
- Q37296336 P2093 Q37296336-491C2DA4-6EF5-4721-9E53-8BF713775F58 @default.
- Q37296336 P2093 Q37296336-7EBFDEAC-1E76-46B7-8043-3A920203A941 @default.
- Q37296336 P2093 Q37296336-93D1BD0A-D259-40CB-BDCD-D5786ADC1E49 @default.
- Q37296336 P2093 Q37296336-A0260074-E4DA-48DF-BD27-C5E7629243F2 @default.
- Q37296336 P2093 Q37296336-A2A0CC38-1CC5-418E-B445-FE6B0FA049DB @default.
- Q37296336 P2860 Q37296336-01B464C9-F299-4ADF-924D-1A63509364CF @default.
- Q37296336 P2860 Q37296336-03FAF56E-823C-4455-9F61-9E17F93A082C @default.
- Q37296336 P2860 Q37296336-1169B412-B5BB-49AE-BADF-841A4FF9D5F7 @default.
- Q37296336 P2860 Q37296336-12E6371F-D2A3-4881-BF24-EBB3AA20B7ED @default.
- Q37296336 P2860 Q37296336-1554F80B-7AC1-49DF-B30D-9189416FE3A7 @default.
- Q37296336 P2860 Q37296336-1BF90731-41D1-4DA7-901A-4EFE3413DDD3 @default.
- Q37296336 P2860 Q37296336-1EDD3480-9BF3-4A18-B491-289C0BCBADF9 @default.
- Q37296336 P2860 Q37296336-264847DC-DC3B-4CE4-AF0F-001C6808FB1C @default.
- Q37296336 P2860 Q37296336-4381E632-B87B-4313-8345-56A545C75630 @default.
- Q37296336 P2860 Q37296336-4600F18A-F577-43F8-B37E-0B6C5EF57F3F @default.
- Q37296336 P2860 Q37296336-4DF8EAFE-A459-4CDA-9842-8F0C6FFFDEB6 @default.
- Q37296336 P2860 Q37296336-501C7FB2-B883-4E39-805D-12B29C9898A0 @default.
- Q37296336 P2860 Q37296336-62111F22-344E-44AB-ACFB-3E52A4E2AED6 @default.
- Q37296336 P2860 Q37296336-6A84C791-1A5B-4F77-8A84-7A532C5C2973 @default.
- Q37296336 P2860 Q37296336-729B2487-CAFF-4A00-8211-C5939B086541 @default.
- Q37296336 P2860 Q37296336-78AE26A4-2232-44FC-AD73-106B5ECAAFC6 @default.
- Q37296336 P2860 Q37296336-7C74910D-6439-4ACD-845A-D44D72AB7E21 @default.
- Q37296336 P2860 Q37296336-82D4718C-C8C6-43B1-B52E-DF4D7BEB377A @default.
- Q37296336 P2860 Q37296336-89679968-3C6F-4158-AA8D-76684DDE05D1 @default.
- Q37296336 P2860 Q37296336-8C2C16F9-8E8A-44B0-9E70-680223A76D77 @default.
- Q37296336 P2860 Q37296336-9DCDA4AB-1B3F-4996-9E07-BCC6EE3369AA @default.
- Q37296336 P2860 Q37296336-A5E06D4C-1457-4EFB-9E04-6ECC80DEDDEE @default.
- Q37296336 P2860 Q37296336-AE53E1A9-D2B0-4BBB-822D-8E380CEEAE01 @default.
- Q37296336 P2860 Q37296336-B04CA132-E4FB-40FC-810B-82BD3E47C41E @default.
- Q37296336 P2860 Q37296336-B0B879E8-64B8-4689-B725-5EB6B065744C @default.
- Q37296336 P2860 Q37296336-B185D33E-D31D-49D1-BC68-B9D3B526FB95 @default.
- Q37296336 P2860 Q37296336-B494353C-7C7B-400C-AD76-02467ACC14DC @default.
- Q37296336 P2860 Q37296336-B84A5D32-1FB7-4A43-9F47-D93563120BF5 @default.
- Q37296336 P2860 Q37296336-BE7840E5-0524-46BD-AEAE-13823A58A5CF @default.
- Q37296336 P2860 Q37296336-C7E8E031-115A-441E-B343-A67CA183D977 @default.
- Q37296336 P2860 Q37296336-CAB9B541-44AB-47A5-ADB4-6B1022791EA2 @default.
- Q37296336 P2860 Q37296336-D4873173-CB81-434D-AAC6-0E1FB490D94D @default.
- Q37296336 P2860 Q37296336-D6B20060-D29B-4176-B67F-3A9B2D192A0E @default.
- Q37296336 P2860 Q37296336-D8DE86FD-2FFB-4A99-8EE1-6C8EA1E23319 @default.
- Q37296336 P2860 Q37296336-E57FE076-4D0C-4361-B439-E3A5D848C91A @default.
- Q37296336 P2860 Q37296336-EFCABE85-C55A-418F-A8B6-13D054D8DF4E @default.
- Q37296336 P2860 Q37296336-F1D31064-FD34-4AD5-BA5A-8C731DEA69FC @default.
- Q37296336 P2860 Q37296336-F51A2A26-3603-4D48-8120-89462CCB2711 @default.
- Q37296336 P304 Q37296336-C06FAF13-2C28-475C-B5BF-2D5A647BFF49 @default.
- Q37296336 P31 Q37296336-0016440A-E161-40A1-8954-1E9C50B0AFEC @default.
- Q37296336 P356 Q37296336-480C9B37-9960-4B16-A0FA-926D6D579294 @default.
- Q37296336 P433 Q37296336-9ED2C2A5-DCBC-4D43-8990-68C6BCCB4A8C @default.
- Q37296336 P478 Q37296336-520ECB74-5A32-4884-A1EE-8F69901EF106 @default.
- Q37296336 P577 Q37296336-82C772DE-7845-4C30-90E8-D135876C997F @default.
- Q37296336 P5875 Q37296336-1766F0D4-97B0-447C-ABDC-87588749D758 @default.
- Q37296336 P698 Q37296336-A96BC2B0-271F-4606-9D69-D290FAF060A1 @default.
- Q37296336 P921 Q37296336-021146B6-91EC-4357-A7E3-74BD17193DBF @default.
- Q37296336 P921 Q37296336-164429AB-6968-43FE-8327-426FE24D83B0 @default.
- Q37296336 P921 Q37296336-34256C5A-785B-4481-88DE-E9C88F8049DE @default.
- Q37296336 P932 Q37296336-F40E10E7-3DF5-42FA-952C-8FD5906FD3C6 @default.
- Q37296336 P356 EURJRHEUMATOL.2014.034 @default.
- Q37296336 P698 27708888 @default.
- Q37296336 P1433 Q27727583 @default.
- Q37296336 P1476 "Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis" @default.
- Q37296336 P2093 "Akif Doğan" @default.
- Q37296336 P2093 "Ayşe Nur Tufan" @default.
- Q37296336 P2093 "Belkıs Nihan Coşkun" @default.
- Q37296336 P2093 "Ediz Dalkılıç" @default.
- Q37296336 P2093 "Mustafa Ferhat Öksüz" @default.
- Q37296336 P2093 "Nurdan Oruçoğlu" @default.
- Q37296336 P2093 "Selime Ermurat" @default.
- Q37296336 P2093 "Yavuz Pehlivan" @default.
- Q37296336 P2860 Q28186087 @default.
- Q37296336 P2860 Q28299001 @default.